Copyright Reports & Markets. All rights reserved.

Global Human Primary Hepatocytes Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Human Primary Hepatocytes by Type
    • 1.3.1 Overview: Global Human Primary Hepatocytes Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Human Primary Hepatocytes Consumption Value Market Share by Type in 2025
    • 1.3.3 Hepatocyte
    • 1.3.4 Cytoplasmic Cells
    • 1.3.5 Hepatic Stellate Cells
    • 1.3.6 Bile Duct Epithelial Cells
    • 1.3.7 Islet Cells
  • 1.4 Global Human Primary Hepatocytes Market by Application
    • 1.4.1 Overview: Global Human Primary Hepatocytes Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Life Science Research Company
    • 1.4.3 Research Institute
    • 1.4.4 Others
  • 1.5 Global Human Primary Hepatocytes Market Size & Forecast
  • 1.6 Global Human Primary Hepatocytes Market Size and Forecast by Region
    • 1.6.1 Global Human Primary Hepatocytes Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Human Primary Hepatocytes Market Size by Region, (2021-2032)
    • 1.6.3 North America Human Primary Hepatocytes Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Human Primary Hepatocytes Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Human Primary Hepatocytes Market Size and Prospect (2021-2032)
    • 1.6.6 South America Human Primary Hepatocytes Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Human Primary Hepatocytes Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Thermo Fisher Scientific, Inc.
    • 2.1.1 Thermo Fisher Scientific, Inc. Details
    • 2.1.2 Thermo Fisher Scientific, Inc. Major Business
    • 2.1.3 Thermo Fisher Scientific, Inc. Human Primary Hepatocytes Product and Solutions
    • 2.1.4 Thermo Fisher Scientific, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
  • 2.2 Merck KGaA
    • 2.2.1 Merck KGaA Details
    • 2.2.2 Merck KGaA Major Business
    • 2.2.3 Merck KGaA Human Primary Hepatocytes Product and Solutions
    • 2.2.4 Merck KGaA Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Merck KGaA Recent Developments and Future Plans
  • 2.3 Lonza
    • 2.3.1 Lonza Details
    • 2.3.2 Lonza Major Business
    • 2.3.3 Lonza Human Primary Hepatocytes Product and Solutions
    • 2.3.4 Lonza Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Lonza Recent Developments and Future Plans
  • 2.4 Cell Biologics, Inc.
    • 2.4.1 Cell Biologics, Inc. Details
    • 2.4.2 Cell Biologics, Inc. Major Business
    • 2.4.3 Cell Biologics, Inc. Human Primary Hepatocytes Product and Solutions
    • 2.4.4 Cell Biologics, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Cell Biologics, Inc. Recent Developments and Future Plans
  • 2.5 PromoCell GmbH
    • 2.5.1 PromoCell GmbH Details
    • 2.5.2 PromoCell GmbH Major Business
    • 2.5.3 PromoCell GmbH Human Primary Hepatocytes Product and Solutions
    • 2.5.4 PromoCell GmbH Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 PromoCell GmbH Recent Developments and Future Plans
  • 2.6 HemaCare Corporation
    • 2.6.1 HemaCare Corporation Details
    • 2.6.2 HemaCare Corporation Major Business
    • 2.6.3 HemaCare Corporation Human Primary Hepatocytes Product and Solutions
    • 2.6.4 HemaCare Corporation Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 HemaCare Corporation Recent Developments and Future Plans
  • 2.7 ZenBio, Inc.
    • 2.7.1 ZenBio, Inc. Details
    • 2.7.2 ZenBio, Inc. Major Business
    • 2.7.3 ZenBio, Inc. Human Primary Hepatocytes Product and Solutions
    • 2.7.4 ZenBio, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 ZenBio, Inc. Recent Developments and Future Plans
  • 2.8 STEMCELL Technologies, Inc.
    • 2.8.1 STEMCELL Technologies, Inc. Details
    • 2.8.2 STEMCELL Technologies, Inc. Major Business
    • 2.8.3 STEMCELL Technologies, Inc. Human Primary Hepatocytes Product and Solutions
    • 2.8.4 STEMCELL Technologies, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 STEMCELL Technologies, Inc. Recent Developments and Future Plans
  • 2.9 Corning Incorporated
    • 2.9.1 Corning Incorporated Details
    • 2.9.2 Corning Incorporated Major Business
    • 2.9.3 Corning Incorporated Human Primary Hepatocytes Product and Solutions
    • 2.9.4 Corning Incorporated Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Corning Incorporated Recent Developments and Future Plans
  • 2.10 Axol Bioscience Ltd.
    • 2.10.1 Axol Bioscience Ltd. Details
    • 2.10.2 Axol Bioscience Ltd. Major Business
    • 2.10.3 Axol Bioscience Ltd. Human Primary Hepatocytes Product and Solutions
    • 2.10.4 Axol Bioscience Ltd. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Axol Bioscience Ltd. Recent Developments and Future Plans
  • 2.11 iXCells Biotechnologies
    • 2.11.1 iXCells Biotechnologies Details
    • 2.11.2 iXCells Biotechnologies Major Business
    • 2.11.3 iXCells Biotechnologies Human Primary Hepatocytes Product and Solutions
    • 2.11.4 iXCells Biotechnologies Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 iXCells Biotechnologies Recent Developments and Future Plans
  • 2.12 Neuromics
    • 2.12.1 Neuromics Details
    • 2.12.2 Neuromics Major Business
    • 2.12.3 Neuromics Human Primary Hepatocytes Product and Solutions
    • 2.12.4 Neuromics Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Neuromics Recent Developments and Future Plans
  • 2.13 BioIVT
    • 2.13.1 BioIVT Details
    • 2.13.2 BioIVT Major Business
    • 2.13.3 BioIVT Human Primary Hepatocytes Product and Solutions
    • 2.13.4 BioIVT Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 BioIVT Recent Developments and Future Plans
  • 2.14 ScienCell Research Laboratories, Inc.
    • 2.14.1 ScienCell Research Laboratories, Inc. Details
    • 2.14.2 ScienCell Research Laboratories, Inc. Major Business
    • 2.14.3 ScienCell Research Laboratories, Inc. Human Primary Hepatocytes Product and Solutions
    • 2.14.4 ScienCell Research Laboratories, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 ScienCell Research Laboratories, Inc. Recent Developments and Future Plans
  • 2.15 Creative Bioarray
    • 2.15.1 Creative Bioarray Details
    • 2.15.2 Creative Bioarray Major Business
    • 2.15.3 Creative Bioarray Human Primary Hepatocytes Product and Solutions
    • 2.15.4 Creative Bioarray Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Creative Bioarray Recent Developments and Future Plans
  • 2.16 BPS Bioscience, Inc.
    • 2.16.1 BPS Bioscience, Inc. Details
    • 2.16.2 BPS Bioscience, Inc. Major Business
    • 2.16.3 BPS Bioscience, Inc. Human Primary Hepatocytes Product and Solutions
    • 2.16.4 BPS Bioscience, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 BPS Bioscience, Inc. Recent Developments and Future Plans
  • 2.17 AcceGen
    • 2.17.1 AcceGen Details
    • 2.17.2 AcceGen Major Business
    • 2.17.3 AcceGen Human Primary Hepatocytes Product and Solutions
    • 2.17.4 AcceGen Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 AcceGen Recent Developments and Future Plans
  • 2.18 Sekisui XenoTech, LLC
    • 2.18.1 Sekisui XenoTech, LLC Details
    • 2.18.2 Sekisui XenoTech, LLC Major Business
    • 2.18.3 Sekisui XenoTech, LLC Human Primary Hepatocytes Product and Solutions
    • 2.18.4 Sekisui XenoTech, LLC Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Sekisui XenoTech, LLC Recent Developments and Future Plans
  • 2.19 Biopredic International
    • 2.19.1 Biopredic International Details
    • 2.19.2 Biopredic International Major Business
    • 2.19.3 Biopredic International Human Primary Hepatocytes Product and Solutions
    • 2.19.4 Biopredic International Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Biopredic International Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Human Primary Hepatocytes Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Human Primary Hepatocytes by Company Revenue
    • 3.2.2 Top 3 Human Primary Hepatocytes Players Market Share in 2025
    • 3.2.3 Top 6 Human Primary Hepatocytes Players Market Share in 2025
  • 3.3 Human Primary Hepatocytes Market: Overall Company Footprint Analysis
    • 3.3.1 Human Primary Hepatocytes Market: Region Footprint
    • 3.3.2 Human Primary Hepatocytes Market: Company Product Type Footprint
    • 3.3.3 Human Primary Hepatocytes Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Human Primary Hepatocytes Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Human Primary Hepatocytes Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Human Primary Hepatocytes Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Human Primary Hepatocytes Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Human Primary Hepatocytes Consumption Value by Type (2021-2032)
  • 6.2 North America Human Primary Hepatocytes Market Size by Application (2021-2032)
  • 6.3 North America Human Primary Hepatocytes Market Size by Country
    • 6.3.1 North America Human Primary Hepatocytes Consumption Value by Country (2021-2032)
    • 6.3.2 United States Human Primary Hepatocytes Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Human Primary Hepatocytes Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Human Primary Hepatocytes Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Human Primary Hepatocytes Consumption Value by Type (2021-2032)
  • 7.2 Europe Human Primary Hepatocytes Consumption Value by Application (2021-2032)
  • 7.3 Europe Human Primary Hepatocytes Market Size by Country
    • 7.3.1 Europe Human Primary Hepatocytes Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Human Primary Hepatocytes Market Size and Forecast (2021-2032)
    • 7.3.3 France Human Primary Hepatocytes Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Human Primary Hepatocytes Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Human Primary Hepatocytes Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Human Primary Hepatocytes Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Human Primary Hepatocytes Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Human Primary Hepatocytes Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Human Primary Hepatocytes Market Size by Region
    • 8.3.1 Asia-Pacific Human Primary Hepatocytes Consumption Value by Region (2021-2032)
    • 8.3.2 China Human Primary Hepatocytes Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Human Primary Hepatocytes Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Human Primary Hepatocytes Market Size and Forecast (2021-2032)
    • 8.3.5 India Human Primary Hepatocytes Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Human Primary Hepatocytes Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Human Primary Hepatocytes Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Human Primary Hepatocytes Consumption Value by Type (2021-2032)
  • 9.2 South America Human Primary Hepatocytes Consumption Value by Application (2021-2032)
  • 9.3 South America Human Primary Hepatocytes Market Size by Country
    • 9.3.1 South America Human Primary Hepatocytes Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Human Primary Hepatocytes Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Human Primary Hepatocytes Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Human Primary Hepatocytes Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Human Primary Hepatocytes Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Human Primary Hepatocytes Market Size by Country
    • 10.3.1 Middle East & Africa Human Primary Hepatocytes Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Human Primary Hepatocytes Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Human Primary Hepatocytes Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Human Primary Hepatocytes Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Human Primary Hepatocytes Market Drivers
  • 11.2 Human Primary Hepatocytes Market Restraints
  • 11.3 Human Primary Hepatocytes Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Human Primary Hepatocytes Industry Chain
  • 12.2 Human Primary Hepatocytes Upstream Analysis
  • 12.3 Human Primary Hepatocytes Midstream Analysis
  • 12.4 Human Primary Hepatocytes Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Human Primary Hepatocytes market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Human primary hepatocytes have the following advantages: they are consistent with the in vivo environment, the levels of enzymes and cofactors are normal physiological concentrations, and drug metabolism and toxicity can be studied close to physiological conditions. It better retains and maintains the complete shape of liver cells and the metabolic activity of liver cells in vitro, truly reflecting the metabolic situation in the body.
    This report is a detailed and comprehensive analysis for global Human Primary Hepatocytes market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Human Primary Hepatocytes market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Human Primary Hepatocytes market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Human Primary Hepatocytes market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Human Primary Hepatocytes market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Human Primary Hepatocytes
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Human Primary Hepatocytes market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Merck KGaA, Lonza, Cell Biologics, Inc., PromoCell GmbH, HemaCare Corporation, ZenBio, Inc., STEMCELL Technologies, Inc., Corning Incorporated, Axol Bioscience Ltd., etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Human Primary Hepatocytes market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Hepatocyte
    Cytoplasmic Cells
    Hepatic Stellate Cells
    Bile Duct Epithelial Cells
    Islet Cells
    Market segment by Application
    Life Science Research Company
    Research Institute
    Others
    Market segment by players, this report covers
    Thermo Fisher Scientific, Inc.
    Merck KGaA
    Lonza
    Cell Biologics, Inc.
    PromoCell GmbH
    HemaCare Corporation
    ZenBio, Inc.
    STEMCELL Technologies, Inc.
    Corning Incorporated
    Axol Bioscience Ltd.
    iXCells Biotechnologies
    Neuromics
    BioIVT
    ScienCell Research Laboratories, Inc.
    Creative Bioarray
    BPS Bioscience, Inc.
    AcceGen
    Sekisui XenoTech, LLC
    Biopredic International
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Human Primary Hepatocytes product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Human Primary Hepatocytes, with revenue, gross margin, and global market share of Human Primary Hepatocytes from 2021 to 2026.
    Chapter 3, the Human Primary Hepatocytes competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Human Primary Hepatocytes market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Human Primary Hepatocytes.
    Chapter 13, to describe Human Primary Hepatocytes research findings and conclusion.

    Buy now